News

Zenas BioPharma company raises $118M | Health IT

By November 8, 2022No Comments

Zenas BioPharma, a biopharmaceutical company specializing in the development of autoimmune disease therapeutics, has raised $118 million in series B financing.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Zenas BioPharma company raises $118M | Health IT

Tags:

Previous PostUniversity of Miami Health System, Siemens partner on medtech, digital health | Health IT

Next PostHealth tech investment down 67% from 2021 peak, and 5 other things to know | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us